Effect of topical diclofenac 0.1% ophthalmic solution on tear production in normal research beagles when administered SID, BID, TID & QID for 5 days
| dc.contributor.author | Colussi, J. A., author | |
| dc.contributor.author | Henriksen, Md. L, author | |
| dc.contributor.author | Martabano, B. B., author | |
| dc.contributor.author | Sharp, J. L., author | |
| dc.contributor.author | Wang, Zeke, author | |
| dc.contributor.author | Lappin, M. R., author | |
| dc.date.accessioned | 2018-11-12T18:04:59Z | |
| dc.date.available | 2018-11-12T18:04:59Z | |
| dc.date.issued | 2018 | |
| dc.description | CSU Ophthalmology. | |
| dc.description.abstract | Purpose. Topical Diclofenac is commonly used for ocular inflammatory diseases in veterinary ophthalmology but no studies have examined the effect of this drug on tear production in dogs. The purpose of this study was to determine the effect of topical Diclofenac on tear production in normal dogs when administered SID, BID, TID, and QID for a 5 day period. Methods. A prospective study with eight normal research beagles. The study consisted of 4x5-day studies where dogs received one drop of topical diclofenac sodium 0.1% ophthalmic solution (Alcon, Fort Worth, TX) to OD-test and one drop of eye wash to OS-control using SID, BID, TID, and QID frequencies with a 16-day washout period between each study. A complete ophthalmic examination was performed including Schirmer’s tear test-I (STT-I) and fluorescein stain the day before each study started (Day-0) and on the last day of each study (Day-5). A linear mixed-effects-model was used to compare tear production (STT-I) between OD-test and OS-control and the four different frequencies. P<0.05 was deemed significant. Results. All dogs in all four studies had a normal ophthalmic examination with no fluorescein stain uptake on Day-0 and Day-5. STT-I mean ± SD values for all four studies: OD-test Day-5 21 ± 3.3mm/min, OS-control Day-5 20 ± 2.2mm/min. There were no significant differences between STT-I OD-test versus OS-control and treatment frequencies (p=0.927). Conclusion. Topical Diclofenac does not appear to have an effect on tear production or cause corneal ulcerations when administered up to four times a day in normal dogs. Funded in part by the Center for Companion Animal Studies Young Investigator Grant program. None. | en_US |
| dc.format.medium | born digital | |
| dc.format.medium | Student works | |
| dc.format.medium | posters | |
| dc.identifier.uri | https://hdl.handle.net/10217/192826 | |
| dc.language | English | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Colorado State University. Libraries | en_US |
| dc.relation.ispartof | 2018 Projects | |
| dc.rights | Copyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright. | |
| dc.subject | tear production | |
| dc.subject | NSAID | |
| dc.subject | Schirmer's tear test-I | |
| dc.subject | diclofenac | |
| dc.title | Effect of topical diclofenac 0.1% ophthalmic solution on tear production in normal research beagles when administered SID, BID, TID & QID for 5 days | en_US |
| dc.title.alternative | 064 - Jenny Colussi | |
| dc.title.alternative | Effect of diclofenac ophthalmic solution on tear production in canines | |
| dc.type | Text | |
| dc.type | Image | |
| dcterms.rights.dpla | This Item is protected by copyright and/or related rights (https://rightsstatements.org/vocab/InC/1.0/). You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). |